Quinazoline derivatives

Details for Australian Patent Application No. 2001278609 (hide)

Owner AstraZeneca AB

Inventors Hennequin, Laurent, Francois, Andre; Lambert, Christine Marie Paul; Ple, Patrick

Agent Davies Collison Cave

Pub. Number AU-B-2001278609

PCT Pub. Number WO02/16352

Priority 00402320 21.08.00 EP; 01401006 19.04.01 EP

Filing date 15 August 2001

Wipo publication date 4 March 2002

Acceptance publication date 14 April 2005

International Classifications

C07D 405/12 Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

A61P 035/00 Antineoplastic agents

A61K 031/517 - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

C07D 405/14 Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

Event Publications

14 April 2005 Application Accepted

  Published as AU-B-2001278609

11 August 2005 Standard Patent Sealed

15 March 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001278610

2001278608